Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats
Xu Zhang, Yufeng Zhao, Jia Xu, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 568

Showing 1-25 of 568 citing articles:

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Hao Wu, Eduardo Esteve, Valentina Tremaroli, et al.
Nature Medicine (2017) Vol. 23, Iss. 7, pp. 850-858
Closed Access | Times Cited: 1370
Blautia—a new functional genus with potential probiotic properties?
Xuemei Liu, Bingyong Mao, Jiayu Gu, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 898
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Lulu Sun, Cen Xie, Guang Wang, et al.
Nature Medicine (2018) Vol. 24, Iss. 12, pp. 1919-1929
Open Access | Times Cited: 801
Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
Jacobo de la Cuesta‐Zuluaga, Noel T. Mueller, Vanessa Corrales-Agudelo, et al.
Diabetes Care (2016) Vol. 40, Iss. 1, pp. 54-62
Open Access | Times Cited: 586
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 10, pp. 569-589
Closed Access | Times Cited: 523
Metformin and Its Benefits for Various Diseases
Ziquan Lv, Yajie Guo
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 410
The quest to slow ageing through drug discovery
Linda Partridge, Matías Fuentealba, Brian K. Kennedy
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 8, pp. 513-532
Closed Access | Times Cited: 359
Gut microbiome and type 2 diabetes: where we are and where to go?
Sapna Sharma, Prabhanshu Tripathi
The Journal of Nutritional Biochemistry (2018) Vol. 63, pp. 101-108
Closed Access | Times Cited: 357
Biological properties and clinical applications of berberine
Danyang Song, Jianyu Hao, Daiming Fan
Frontiers of Medicine (2020) Vol. 14, Iss. 5, pp. 564-582
Closed Access | Times Cited: 331
Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial
Xiaolin Tong, Jia Xu, Fengmei Lian, et al.
mBio (2018) Vol. 9, Iss. 3
Open Access | Times Cited: 325
Metformin: update on mechanisms of action and repurposing potential
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 460-476
Open Access | Times Cited: 323
Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Xiaojun Feng, Antoni Sureda, Samineh Jafari, et al.
Theranostics (2019) Vol. 9, Iss. 7, pp. 1923-1951
Open Access | Times Cited: 322
Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities
Qiang Zeng, Dongfang Li, Yuan He, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 315
Phascolarctobacterium faecium abundant colonization in human gastrointestinal tract
Feifan Wu, Xianfeng Guo, Jiachun Zhang, et al.
Experimental and Therapeutic Medicine (2017) Vol. 14, Iss. 4, pp. 3122-3126
Open Access | Times Cited: 307
Metformin: Mechanisms in Human Obesity and Weight Loss
Armen Yerevanian, Alexander A. Soukas
Current Obesity Reports (2019) Vol. 8, Iss. 2, pp. 156-164
Open Access | Times Cited: 305
Research progress on berberine with a special focus on its oral bioavailability
Chang‐Shun Liu, Yurong Zheng, Yingfeng Zhang, et al.
Fitoterapia (2016) Vol. 109, pp. 274-282
Closed Access | Times Cited: 301
Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health—Pathophysiology and Therapeutic Strategies
Judith Aron‐Wisnewsky, Moritz V. Warmbrunn, Max Nieuwdorp, et al.
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 573-599
Open Access | Times Cited: 289
Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota
Jun Xu, Hubiao Chen, Song‐Lin Li
Medicinal Research Reviews (2017) Vol. 37, Iss. 5, pp. 1140-1185
Closed Access | Times Cited: 285
Blueberry polyphenols extract as a potential prebiotic with anti-obesity effects on C57BL/6 J mice by modulating the gut microbiota
Xinyao Jiao, Yuehua Wang, Yang Lin, et al.
The Journal of Nutritional Biochemistry (2018) Vol. 64, pp. 88-100
Closed Access | Times Cited: 268
The chicken gut metagenome and the modulatory effects of plant-derived benzylisoquinoline alkaloids
Peng Huang, Yan Zhang, Kangpeng Xiao, et al.
Microbiome (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 268
Differential Changes in Gut Microbiota After Gastric Bypass and Sleeve Gastrectomy Bariatric Surgery Vary According to Diabetes Remission
Rinki Murphy, Peter Tsai, Mia Jüllig, et al.
Obesity Surgery (2016) Vol. 27, Iss. 4, pp. 917-925
Closed Access | Times Cited: 257
Advancing functional and translational microbiome research using meta-omics approaches
Xu Zhang, Leyuan Li, James Butcher, et al.
Microbiome (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 257
Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice
Pan Wang, Daotong Li, Weixin Ke, et al.
International Journal of Obesity (2019) Vol. 44, Iss. 1, pp. 213-225
Closed Access | Times Cited: 250
Berberine pharmacology and the gut microbiota: A hidden therapeutic link
Solomon Habtemariam
Pharmacological Research (2020) Vol. 155, pp. 104722-104722
Closed Access | Times Cited: 235
In vitro digestion under simulated saliva, gastric and small intestinal conditions and fermentation by human gut microbiota of polysaccharides from the fruits of Lycium barbarum
Yu Ding, Yamei Yan, Yujia Peng, et al.
International Journal of Biological Macromolecules (2018) Vol. 125, pp. 751-760
Closed Access | Times Cited: 233
Page 1 - Next Page

Scroll to top